---
title: "Keshun invested in the establishment of a green building materials company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242109281.md"
description: "According to the Qichacha APP, recently, Kema Green Building Materials Co., Ltd. was established, with Liu Xin as the legal representative and a registered capital of 12 million yuan. The business scope includes: sales of cement products; manufacturing of new building materials; sales of building materials; sales of lightweight building materials; sales of building waterproofing membrane products; sales of refractory materials, etc. Qichacha's equity penetration shows that the company is wholly owned by Jiangsu Zhenjiang Kema New Materials Technology Co., Ltd., a subsidiary of Keshun"
datetime: "2025-05-28T02:36:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242109281.md)
  - [en](https://longbridge.com/en/news/242109281.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242109281.md)
generator: "portal-rs"
---

# Keshun invested in the establishment of a green building materials company

According to the Qichacha APP, recently, Kema Green Building Materials Co., Ltd. was established, with Liu Xin as the legal representative and a registered capital of 12 million yuan. The business scope includes: sales of cement products; manufacturing of new building materials; sales of building materials; sales of lightweight building materials; sales of building waterproofing membrane products; sales of refractory materials, etc. Qichacha's equity penetration shows that the company is wholly owned by Jiangsu Zhenjiang Kema New Materials Technology Co., Ltd., a subsidiary of Keshun

### Related Stocks

- [300737.CN](https://longbridge.com/en/quote/300737.CN.md)
- [CP00002.US](https://longbridge.com/en/quote/CP00002.US.md)

## Related News & Research

- [BYD launches Sealion 08 SUV, bolstering Ocean lineup's flagship push](https://longbridge.com/en/news/297765654.md)
- [Denmark sends conscripts to Greenland as Arctic tensions grow](https://longbridge.com/en/news/297744144.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)
- [Prostatype Genomics secures about 70% coverage for upcoming warrant exercise, targeting up to SEK 12.5 million](https://longbridge.com/en/news/297486162.md)
- [CMA: Gross profit doubled and FY27 revenue is forecast to grow over 80% as scale and margins improve](https://longbridge.com/en/news/297444189.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**